168 related articles for article (PubMed ID: 28414416)
1. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J
J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors].
Garrido A; Iborra MI; Saperas E; de Sousa M;
Med Clin (Barc); 2010 May; 134(13):577-82. PubMed ID: 20189198
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
[No Abstract] [Full Text] [Related]
4. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.
Conrad SA; Gabrielli A; Margolis B; Quartin A; Hata JS; Frank WO; Bagin RG; Rock JA; Hepburn B; Laine L
Crit Care Med; 2005 Apr; 33(4):760-5. PubMed ID: 15818102
[TBL] [Abstract][Full Text] [Related]
5. The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.
Zhang W; Han Y; Fort JG; Schofield D; Tursi JP
J Med Econ; 2017 Jun; 20(6):592-598. PubMed ID: 28145783
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
7. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
[TBL] [Abstract][Full Text] [Related]
8. The comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients.
Dabiri Y; Fahimi F; Jamaati H; Hashemian SM
Indian J Crit Care Med; 2015 Jan; 19(1):21-6. PubMed ID: 25624646
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
[TBL] [Abstract][Full Text] [Related]
10. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
Ojiako K; Shingala H; Schorr C; Gerber DR
Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
[TBL] [Abstract][Full Text] [Related]
11. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
12. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
13. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
van Hout BA; Klok RM; Brouwers JR; Postma MJ
Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
15. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
[TBL] [Abstract][Full Text] [Related]
17. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Hashiguchi M; Yamauchi N; Uchikura T; Mochizuki M
Yakugaku Zasshi; 2008 Apr; 128(4):585-94. PubMed ID: 18379175
[TBL] [Abstract][Full Text] [Related]
18. [Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole].
García González F; Soler Company E; Hedo Aparicio G
Farm Hosp; 2003; 27(6):339-45. PubMed ID: 14974879
[TBL] [Abstract][Full Text] [Related]
19. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
20. Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.
Maton PN
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():45-52. PubMed ID: 16303037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
